ALKYLATING AGENT
| The Cytoxan brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your healthcare provider about safe options for transitioning to a different treatment. |
Overview
Cytoxan was a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating cancers including Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma. Cytoxan was often combined with other drugs such as vincristine sulfate, bortezomib, and corticosteroids in a chemotherapy regimen. Cytoxan was also known by its drug name, cyclophosphamide
Cytoxan was an anticancer drug used in chemotherapy. Cytoxan was a member of a class of drugs called alkylating agents. Cytoxan was believed to work by preventing the production of DNA in cells, thereby blocking cell division and inhibiting cancer growth.
How was it taken?
Cytoxan could be administered as an IV infusion, taken orally, or injected into muscles.
Side effects
Common side effects of Cytoxan included fever, nausea, vomiting, diarrhea, temporary hair loss, darkening of the skin and nails, loss of appetite, fatigue, increased risk of infection, anemia, and low white blood cell counts.
Serious side effects of Cytoxan included urinary tract toxicity, pulmonary toxicity, cardiotoxicity, the risk of permanent infertility, and increased risk of some types of cancer, even years after treatment has stopped.
For more details about this treatment, visit:
More resources from MyLymphomaTeam that mention Cytoxan
Become a member to get even more